Outcome of Board Meeting

Medplus Health Services Limited July 21, 2026 The Listing Department The Listing Department BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Outcome of Board meeting under SEBI (Listing Obligation and Disclosure requirements) Regulations 2015 (Listing Regulations) In furtherance to our letter dated July 07, 2026, and pursuant to Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company, at their meeting held today i.e., July 21, 2026, approved/noted the followings: 1. The Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026, along with Limited Review Report received from the M/s B S R and Co, Chartered Accountants (Firm registration Number 128510W) Statutory Auditors of the Company. A copy of the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026 along with Limited Review Report thereon is enclosed as Annexure-A. 2. CAPEX Plan for setting up of Food Park including Cold Press Oil Extraction Unit at Hyderabad, Telangana by Optival Health Solutions Private Limited (Material Subsidiary). The proposed project entails CAPEX of approximately Rs. 400 million, towards development of land, construction of building, procurement and installation of unit and machinery, utilities, filling and packing lines, and other project-related capital expenditure. 3. CAPEX Plan for setting up a Concierge Health & Wellness Services Facility at Hyderabad, Telangana. The proposed service facility is intended to provide preventive healthcare, diagnostics, specialist consultations and wellness services through a subscription-based membership model. The estimated investment for the project is approximately Rs. 1150 million, comprising capital expenditure of Rs. 900 million. 4. Based on the recommendation of Nomination and Remuneration Committee, the Board approved the appointment of Mr. Shrenik Soni (M. No.: F12400) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company w.e.f July 21, 2026, subject to such terms and conditions as approved by the Board of Directors. 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com Medplus Health Services Limited In view of the above and pursuant to Regulation 30(5) of the SEBI LODR Regulations the contact details of Mr. Shrenik Soni, authorised as KMP under the Company’s Policy on criteria for determining the materiality for disclosure of events or information with effect from July 21, 2026 are as follows: Particulars Details Company MedPlus Health Services Limited Name Mr. Shrenik Soni Designation Company Secretary and Compliance Officer (Key Managerial Personnel) Contact Number 040-6724-6724 Email shrenik.s@medplusindia.com Address H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, (Moosapet), Kukatpally, Hyderabad - 500 037, Telangana, India. The details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master Circular No. H0/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 are given as Annexure-B. The meeting commenced at 02:00 PM and concluded at 4:30 PM. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Gangadi Madhukar Reddy Managing Director and CEO (DIN: 00098097) Encl: a/a 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com B S R and Co Salarpuria Knowledge City, Orwell Et Wing, 6th Floor, Unit-3, Sy No. 83/1 Plot No. 02, Raidurg Chartered Accountants Hyderabad — 500 081, India Telephone + 91 407 182 2000 Fax + 91 407 182 2399 Limited Review Report on unaudited consolidated financial results of MedPlus Health Services Limited for the quarter ended 30 June 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of MedPlus Health Services Limited 1. We have reviewed the accompanying Statement of unaudited consolidated financial results of MedPlus Health Services Limited (hereinafter referred to as "the Parent"), and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group") for the quarter ended 30 June 2026 ("the Statement") (in which are included interim financial information of Medplus Employees Benefit Trust ("Trust")), being submitted by the Parent pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). 2. This Statement, which is the responsibility of the Parent's management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33(8) of the Listing Regulations, to the extent applicable. 4. The Statement includes the results of the entities mentioned in Annexure Ito the Statement. 5. Attention is drawn to the fact that the figures for the three months ended 31 March 2026 as reported in the Statement are the balancing figures between audited figures in respect of the full previous financial year and the published year to date figures up to the third quarter of the previous financial year. The figures up to the end of the third quarter of previous financial year had only been reviewed and not subjected to audit. 6. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the [Showing first 8,000 characters — download PDF for full document]